Share Name Share Symbol Market Type Share ISIN Share Description
Netscientific Plc LSE:NSCI London Ordinary Share GB00BN4R5Q82 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 62.00 60.00 64.00 62.00 62.00 62.00 7,919 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 1.1 -2.9 -13.2 - 14

NetScientific Shares Rise After FDA Meeting on HPV Carcinoma Therapy

03/10/2022 3:10pm

Dow Jones News

Netscientific (LSE:NSCI)
Historical Stock Chart

From Aug 2022 to Feb 2023

Click Here for more Netscientific Charts.

By Michael Susin


NetScientific PLC shares rose on Monday after the company said that its portfolio company PDS Biotechnology Corp. has successfully completed an end-of-Phase-2 meeting with the U.S. Food and Drug Administration regarding the combination of its treatment with Merck & Co.'s therapy for papillomavirus carcinoma.

Shares at 1307 GMT were up 0.05 pence, or 13%, at 0.5 pence.

The life-sciences and technology investment company said that PDS has received guidance from FDA on key elements to submit a biologics license application for its PDS0101 asset treatment.

The end-of-Phase-2 meeting was to determine the safety of proceeding to the last phase of the study and identify any additional information necessary to support a marketing application for the uses under investigation.

The combined therapies are targeting the treatment of unresectable, recurrent and metastatic human-papillomavirus-16-positive head-and-neck squamous-cell carcinoma, the company added.

"We are pleased with PDS's continued and systematic progress on its business objectives, despite unfavorable capital markets conditions. Building on momentum from the FDA Fast Track designation in June 2022, and the subsequent $35 million venture debt facility in August 2022, PDS is now well positioned for further progress in its PDS0101 clinical program." Chief Executive Officer Dr. Ilian Iliev said.


Write to Michael Susin at


(END) Dow Jones Newswires

October 03, 2022 09:55 ET (13:55 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

1 Year Netscientific Chart

1 Year Netscientific Chart

1 Month Netscientific Chart

1 Month Netscientific Chart
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20230207 05:32:44